Research analysts at Wolfe Research started coverage on shares of Aurora Innovation (NASDAQ:AUR – Get Free Report) in a note issued to investors on Tuesday, Marketbeat.com reports. The firm set a “peer perform” rating on the stock.
Several other research analysts have also recently issued reports on AUR. The Goldman Sachs Group upped their price target on Aurora Innovation from $2.00 to $2.50 and gave the company a “sell” rating in a report on Monday, November 4th. Evercore ISI upped their price target on shares of Aurora Innovation from $3.00 to $5.00 and gave the company an “in-line” rating in a research report on Monday, October 14th. Canaccord Genuity Group reaffirmed a “buy” rating and issued a $7.00 target price on shares of Aurora Innovation in a research report on Monday, September 30th. Finally, TD Cowen increased their price objective on Aurora Innovation from $3.00 to $4.00 and gave the stock a “hold” rating in a research note on Thursday, October 31st. One investment analyst has rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the stock. According to MarketBeat, Aurora Innovation presently has a consensus rating of “Hold” and an average price target of $4.63.
Read Our Latest Research Report on AUR
Aurora Innovation Stock Up 7.3 %
Insider Buying and Selling at Aurora Innovation
In other news, Director Reid Hoffman sold 447,046 shares of the company’s stock in a transaction dated Friday, November 15th. The stock was sold at an average price of $5.04, for a total transaction of $2,253,111.84. Following the completion of the sale, the director now owns 26,892 shares in the company, valued at approximately $135,535.68. This represents a 94.33 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Gloria R. Boyland sold 30,000 shares of the business’s stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $6.30, for a total value of $189,000.00. Following the completion of the sale, the director now owns 344,647 shares of the company’s stock, valued at approximately $2,171,276.10. This trade represents a 8.01 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 8,776,667 shares of company stock worth $48,432,337 over the last 90 days. 13.83% of the stock is currently owned by corporate insiders.
Institutional Trading of Aurora Innovation
Several hedge funds have recently added to or reduced their stakes in AUR. Franklin Resources Inc. acquired a new position in Aurora Innovation during the 3rd quarter valued at $72,000. Virtu Financial LLC acquired a new position in shares of Aurora Innovation during the third quarter valued at about $337,000. Geode Capital Management LLC grew its position in Aurora Innovation by 15.5% during the third quarter. Geode Capital Management LLC now owns 22,796,526 shares of the company’s stock worth $134,981,000 after buying an additional 3,064,342 shares in the last quarter. Abel Hall LLC bought a new position in Aurora Innovation during the third quarter valued at about $88,000. Finally, Barclays PLC lifted its position in shares of Aurora Innovation by 431.9% in the 3rd quarter. Barclays PLC now owns 1,709,749 shares of the company’s stock worth $10,122,000 after acquiring an additional 1,388,307 shares during the period. Institutional investors own 44.71% of the company’s stock.
Aurora Innovation Company Profile
Aurora Innovation, Inc operates as a self-driving technology company in the United States. It focuses on developing Aurora Driver, a platform that brings a suite of self-driving hardware, software, and data services together to adapt and interoperate vehicles. The company was founded in 2017 and is headquartered in Pittsburgh, Pennsylvania.
Featured Articles
- Five stocks we like better than Aurora Innovation
- 3 Monster Growth Stocks to Buy Now
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Options Trading – Understanding Strike Price
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Aurora Innovation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Innovation and related companies with MarketBeat.com's FREE daily email newsletter.